Esophageal Cancer,Gastric Cancer,Gastrointestinal Cancer BLU-222 Phase 1 Monotherapy Dose Escalation in Solid Tumors Sep 26, 2023
Esophageal Cancer,Gastrointestinal Cancer Pembrolizumab Plus Trastuzumab and Chemotherapy for HER2+ Metastatic G/GEJ cancer Aug 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Analyzing Resected Esophageal or Gastroesophageal Junction Cancer in Adjuvant Nivolumab Aug 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Tislelizumab + Chemo vs. Placebo + Chemo as 1L Treatment for Advanced Esophageal Cancer May 02, 2023
Esophageal Cancer,Gastrointestinal Cancer A Cost-Effectiveness Analysis on Pembrolizumab +Chemo vs. Chemo Alone for Advanced Esophageal Cancer Apr 28, 2023
Esophageal Cancer,Gastrointestinal Cancer SPOTLIGHT Trial: Zolbetuximab + mFOLFOX6 for Gastric Cancer Treatment Mar 03, 2023
Esophageal Cancer,Gastrointestinal Cancer Efficacy of T-DXd in HER2-Positive Gastric Cancer: Phase 2 Retrospective Study Mar 03, 2023
Esophageal Cancer,Gastrointestinal Cancer CheckMate-649: Nivolumab Combo vs. Chemotherapy for Advanced Gastric Cancer Mar 03, 2023